• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

慢性肝脏疾病的肺血管并发症：病理生理学、影像学和治疗。

Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.

机构信息

North Manchester General Hospital, Manchester, Pennine Acute Hospitals NHS Trust, UK.

出版信息

Ann Thorac Med. 2011 Apr;6(2):57-65. doi: 10.4103/1817-1737.78412.

DOI:10.4103/1817-1737.78412
PMID:21572693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3081557/
Abstract

To review the pathogenesis of pulmonary vascular complications of liver disease, we discuss their clinical implications, and therapeutic considerations, with emphasis on potential reversibility of the hepatopulmonary syndrome after liver transplantation. In this review, we also discuss the role of imaging in pulmonary vascular complications associated with liver disease.

摘要

为了回顾肝脏疾病肺血管并发症的发病机制，我们讨论了其临床意义和治疗注意事项，重点强调了肝移植后肝肺综合征的潜在可逆性。在这篇综述中，我们还讨论了影像学在与肝脏疾病相关的肺血管并发症中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/c0059d276a98/ATM-6-57-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/691969d111a5/ATM-6-57-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/444c2fab8f95/ATM-6-57-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/61a5417a85e8/ATM-6-57-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/79ba35f966c4/ATM-6-57-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/34abcf7eccf7/ATM-6-57-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/f02539a8bc45/ATM-6-57-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/7af01aa396ca/ATM-6-57-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/fd5af97afd5c/ATM-6-57-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/aad4039aa709/ATM-6-57-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/e02f7e719928/ATM-6-57-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/e42b00a5b49d/ATM-6-57-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/8301897d255d/ATM-6-57-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/c0059d276a98/ATM-6-57-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/691969d111a5/ATM-6-57-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/444c2fab8f95/ATM-6-57-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/61a5417a85e8/ATM-6-57-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/79ba35f966c4/ATM-6-57-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/34abcf7eccf7/ATM-6-57-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/f02539a8bc45/ATM-6-57-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/7af01aa396ca/ATM-6-57-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/fd5af97afd5c/ATM-6-57-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/aad4039aa709/ATM-6-57-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/e02f7e719928/ATM-6-57-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/e42b00a5b49d/ATM-6-57-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/8301897d255d/ATM-6-57-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a8/3081557/c0059d276a98/ATM-6-57-g013.jpg

相似文献

1
Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.慢性肝脏疾病的肺血管并发症：病理生理学、影像学和治疗。
Ann Thorac Med. 2011 Apr;6(2):57-65. doi: 10.4103/1817-1737.78412.
2
Hepatopulmonary syndrome and portopulmonary hypertension.肝肺综合征和门肺高血压。
Hepatol Res. 2009 Oct;39(10):1020-2. doi: 10.1111/j.1872-034X.2009.00552.x.
3
Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.肝肺综合征与门肺高压：发病机制的最新认识及临床评估概述
Liver Int. 2015 Jun;35(6):1646-60. doi: 10.1111/liv.12791. Epub 2015 Feb 16.
4
Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.共存的肝肺综合征和门肺高压：对肝移植的影响。
J Clin Gastroenterol. 2010 Aug;44(7):e136-40. doi: 10.1097/MCG.0b013e3181da76fc.
5
Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome.一名患有既往肝肺综合征的患者在肝移植后出现严重的门肺高压。
J Hepatol. 1999 Dec;31(6):1075-9. doi: 10.1016/s0168-8278(99)80321-3.
6
Pulmonary vascular disorders in portal hypertension.门静脉高压症中的肺血管疾病
Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153.
7
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.肺移植的禁忌证、适应证和 MELD 例外：当代观点与展望。
J Hepatol. 2013 Aug;59(2):367-74. doi: 10.1016/j.jhep.2013.03.026. Epub 2013 Apr 1.
8
Pulmonary vascular complications in portal hypertension and liver disease: a concise review.门静脉高压症和肝病中的肺血管并发症：简要综述
Rev Gastroenterol Mex. 2013 Jan-Mar;78(1):35-44. doi: 10.1016/j.rgmx.2012.10.004. Epub 2013 Jan 28.
9
[Pulmonary complications of liver cirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax].肝硬化的肺部并发症：肝肺综合征、门脉性肺动脉高压和肝性胸水
Internist (Berl). 2010 Mar;51 Suppl 1:255-63. doi: 10.1007/s00108-009-2503-y.
10
Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.肝移植后并存门肺高压和肝肺综合征患者对西地那非的反应
Exp Clin Transplant. 2017 Dec;15(6):693-695. doi: 10.6002/ect.2015.0210. Epub 2016 Mar 21.

引用本文的文献

1
Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial.仰卧位与直立位运动对肝肺综合征伴直立性低氧血症患者的影响：一项随机对照交叉试验的研究方案。
Trials. 2021 Oct 9;22(1):683. doi: 10.1186/s13063-021-05633-7.
2
Pulmonary Complications in Candidates for Liver Transplantation.肝移植候选者的肺部并发症
Middle East J Dig Dis. 2020 Jul;12(3):145-153. doi: 10.34172/mejdd.2020.176.
3
Assessing the kinetics of microbubble appearance in cirrhotic patients using transthoracic saline contrast-enhanced echocardiography.

本文引用的文献

1
Portopulmonary hypertension: challenges in diagnosis and management.肝肺高压：诊断与治疗面临的挑战。
Therap Adv Gastroenterol. 2009 Sep;2(5):281-6. doi: 10.1177/1756283X09338431.
2
Pharmacotherapeutic management of pulmonary arterial hypertension.肺动脉高压的药物治疗管理。
Cardiol Rev. 2010 May-Jun;18(3):148-62. doi: 10.1097/CRD.0b013e3181d4e921.
3
(99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.
使用经胸盐水对比增强超声心动图评估肝硬化患者微泡出现的动力学。
Echocardiography. 2017 Oct;34(10):1439-1446. doi: 10.1111/echo.13662. Epub 2017 Aug 25.
4
Hepatopulmonary Syndrome.肝肺综合征
Dig Dis Sci. 2015 Jul;60(7):1914-23. doi: 10.1007/s10620-015-3593-0. Epub 2015 Mar 3.
5
Cirrhosis and hepatopulmonary syndrome.肝硬化与肝肺综合征。
World J Gastroenterol. 2014 Mar 14;20(10):2586-94. doi: 10.3748/wjg.v20.i10.2586.
6
The end-organ impairment in liver cirrhosis: appointments for critical care.肝硬化中的终末器官损害：重症监护要点
Crit Care Res Pract. 2012;2012:539412. doi: 10.1155/2012/539412. Epub 2012 May 16.
锝-99m 聚合白蛋白肺灌注扫描与对比增强超声心动图在慢性肝病儿童肝肺综合征诊断中的比较。
Eur J Gastroenterol Hepatol. 2010 Aug;22(8):1006-12. doi: 10.1097/MEG.0b013e328336562e.
4
Hepatopulmonary syndrome: an update.肝肺综合征：最新进展
Sao Paulo Med J. 2009 Jul;127(4):223-30. doi: 10.1590/s1516-31802009000400008.
5
Findings of hepatopulmonary syndrome on breath-hold perfusion SPECT-CT fusion images.屏气灌注单光子发射计算机断层扫描-计算机断层扫描融合图像上肝肺综合征的表现。
Ann Nucl Med. 2009 Jun;23(4):413-9. doi: 10.1007/s12149-009-0250-8. Epub 2009 Apr 25.
6
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.晚期肝病患者门肺高压的遗传风险因素
Am J Respir Crit Care Med. 2009 May 1;179(9):835-42. doi: 10.1164/rccm.200809-1472OC. Epub 2009 Feb 12.
7
Portopulmonary hypertension: state of the art.门肺高压：最新进展
Ann Hepatol. 2008 Oct-Dec;7(4):321-30.
8
Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease.小儿终末期肝病肺血管并发症的肝移植治疗
J Pediatr Surg. 2008 Oct;43(10):1813-20. doi: 10.1016/j.jpedsurg.2008.04.002.
9
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.肝肺综合征对肝移植候选者生活质量和生存的影响。
Gastroenterology. 2008 Oct;135(4):1168-75. doi: 10.1053/j.gastro.2008.06.038. Epub 2008 Jun 20.
10
Pulmonary hypertension in patients with congenital portosystemic venous shunt: a previously unrecognized association.先天性门体静脉分流患者的肺动脉高压：一种先前未被认识到的关联。
Pediatrics. 2008 Apr;121(4):e892-9. doi: 10.1542/peds.2006-3411. Epub 2008 Mar 24.